SHIJIAZHUANG CITY, China--(BUSINESS WIRE)--Lianhua Qingwen Capsule, a Chinese traditional medicine made by Yiling Pharmaceutical, has played an important role in China’s COVID-19 prevention and control. The herb medicine has the effects of clearing away the plague, detoxifying, releasing lung heat. Lianhua Qingwen has been approved by the Food and Drug Administration of the Philippines and become officially registered in the Philippines. It entered the Philippine market on November 23.
In August 2020, spokesperson from the Embassy of the People’s Republic of China in the Philippines has specially issued The Statement on Lianhua Qingwen Capsule Obtaining Philippine Drug Registration Certificate, to congratulate the approval.
The statement pointed out that the embassy was very pleased to learn the Food and Drug Administration of the Philippines had officially approved Lianhua Qingwen Capsule produced by Yiling Pharmaceutical, making it a traditional Chinese medicine product officially registered in the Philippines.
The statement shows that Lianhua Qingwen Capsule has obtained listing license in nearly 20 countries, including Brazil, Indonesia, Canada, Mozambique, Romania, Thailand, Ecuador, Singapore and Laos. It is expected that after entering the Philippine market, Lianhua Qingwen can help effectively curb the spread of the coronavirus and help Philippine patients with mild symptoms quickly recover.
The Chinese Embassy hopes that Philippine consumers purchase and use qualified traditional Chinese medicine products produced by regular manufacturers, and expect Chinese medicine products to play a greater role in fighting COVID-19 in the Philippines.
It is reported that the registration No. of Lianhua Qingwen in the Philippines is THPR-50, with product category as a traditionally-used herbal product. At present, consumers in the Philippines can purchase Lianhua Qingwen at the Southstar Drug, and is going to be on sale at Watsons and Mercury Drug also.